You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (98)

Journals (0)

1-10 of 98 results for HER2 mutation

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Association between HER2 germline mutation A270S and prognosis in patients with primary breast cancer

Free access

Research article

First published 2018-5

Association between HER2 germline mutation A270S and prognosis in patients with primary breast cancer

Pilei Si, Ye Xu, Tao Ouyang [...]

Cancer Biomarkers

Select article: Frequency,impact and a preclinical study of novel ERBB gene family mutations in HER2-positive breast cancer

Open access

Research article

First published 2018

Frequency,impact and a preclinical study of novel ERBB gene family mutations in HER2-positive breast cancer

Naomi Elster, Sinead Toomey, Yue Fan [...]

Therapeutic Advances in Medical Oncology

Select article: Economic Evaluation of Inavolisib Combined With Palbociclib–Fulvestrant for PIK3CA-Mutated,HR+/HER2− Advanced Breast Cancer in USA

Open access

Research article

First published 2026

Economic Evaluation of Inavolisib Combined With Palbociclib–Fulvestrant for PIK3CA-Mutated,HR+/HER2− Advanced Breast Cancer in USA

Hanqing Zeng, Li-Ying Song, Ren Guo [...]

Technology in Cancer Research & Treatment

Select article: Combination regimens as potential treatment of non-small-cell lung cancer patients with HER2 mutation in the real world: a multicenter study

Open access

Research article

First published 2025

Combination regimens as potential treatment of non-small-cell lung cancer patients with HER2 mutation in the real world: a multicenter study

Yue Hao, Qian Wang, Ke Wang [...]

Therapeutic Advances in Medical Oncology

Select article: Advances and Future Perspectives of HER2 Mutations in Non-Small Lung Cancer (NSCLC),Especially in China

Open access

Review article

First published 2025-05

Advances and Future Perspectives of HER2 Mutations in Non-Small Lung Cancer (NSCLC),Especially in China

Chang Liu, Tao Li, Xiaoran Cui [...]

Cancer Control

Select article: Olaparib in hormone receptor-positive,HER2-negative metastatic breast cancer with a somatic BRCA2 mutation

Open access

Case report

First published 2021

Olaparib in hormone receptor-positive,HER2-negative metastatic breast cancer with a somatic BRCA2 mutation

Lee S. Schwartzberg, Lesli A. Kiedrowski

Therapeutic Advances in Medical Oncology

Select article: HR-positive/HER2-negative breast cancer arising in patients with or without BRCA2 mutation: different biological phenotype and similar prognosis

Open access

Research article

First published 2024

HR-positive/HER2-negative breast cancer arising in patients with or without BRCA2 mutation: different biological phenotype and similar prognosis

Pu-Chun Li, Yi-Fan Zhu, Jia-Ni Pan [...]

Therapeutic Advances in Medical Oncology

Select article: Efficacy and safety of phosphoinositide 3-kinase inhibitors and AKT-inhibitors in combination with fulvestrant in PIK3CA mutated,HR-positive,HER2-negative invasive breast cancer: A systematic review

Retricted access

Research article

First published 2025

Efficacy and safety of phosphoinositide 3-kinase inhibitors and AKT-inhibitors in combination with fulvestrant in PIK3CA mutated,HR-positive,HER2-negative invasive breast cancer: A systematic review

Chris Larck, Joseph B Elmes, R. Wesley Haynes [...]

Journal of Oncology Pharmacy Practice

Select article: Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline BRCA1 / 2 mutations and hormone receptor status from the phase-3 BROCADE3 trial

Open access

Research article

First published 2021

Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline BRCA1 / 2 mutations and hormone receptor status from the phase-3 BROCADE3 trial

Jean-Pierre Ayoub, Hans Wildiers, Michael Friedlander [...]

Therapeutic Advances in Medical Oncology

Select article: Clinical outcomes of patients with HER2 -mutant advanced lung cancer: chemotherapies versus HER2 -directed therapies

Open access

Research article

First published 2020

Clinical outcomes of patients with HER2 -mutant advanced lung cancer: chemotherapies versus HER2 -directed therapies

Jiebai Zhou, Ning Ding, Xiaobo Xu [...]

Therapeutic Advances in Medical Oncology

1
2
3
•••
10
10 / page

Article type

Publication date

Subjects

Access